INR vs USD: Rupee near 97/dollar; how TCS, Sun Pharma, Tata Steel, SRF may gain from weaker currency? Experts explain

Against that, the stock is -0.2% on the day at ₹2,077.00, and has returned +2.1% over three months. It sits 38% below its 52-week high, which means a good deal of bad news was already in the price. The it sector has moved +1.1% over the same period, so Tata Consultancy is running 1.0 points ahead of its peers.

This is an Input cost / crude event. India imports most of its crude, so input costs pass through to margins downstream and to the rupee. Producers and consumers of the same input move in opposite directions. On the day the stock is -0.2%, so the price barely moved, which suggests this was expected or is seen as immaterial.

With Tata Consultancy, Sun Pharmaceutical and Tata Steel all implicated, this reads as a IT-level move rather than a company-specific one, which is the more durable kind of signal.